Denny W A
Auckland Cancer Society Research Centre, School of Biomedical and Health Sciences, The University of Auckland, Auckland, Private Bag 92109, New Zealand.
Curr Med Chem. 2001 Apr;8(5):533-44. doi: 10.2174/0929867003373283.
Recent work on a number of different classes of anticancer agents that alkylate DNA in the minor groove is reviewed. There has been much work with nitrogen mustards, where attachment of the mustard unit to carrier molecules can change the normal patterns of both regio- and sequence-selectivity, from reaction primarily at most guanine N7 sites in the major groove to a few adenine N3 sites at the 3'-end of poly(A/T) sequences in the minor groove. Carrier molecules discussed for mustards are intercalators, polypyrroles, polyimidazoles, bis(benzimidazoles), polybenzamides and anilinoquinolinium salts. In contrast, similar targeting of pyrrolizidine alkylators by a variety of carriers has little effect of their patterns of alkylation (at the 2-amino group of guanine). Recent work on the pyrrolobenzodiazepine and cyclopropaindolone classes of natural product minor groove binders is also reviewed.
本文综述了近期关于多种在小沟中使DNA烷基化的不同类型抗癌药物的研究工作。关于氮芥类药物已有大量研究,其中氮芥单元与载体分子的连接可改变区域选择性和序列选择性的正常模式,从主要在大沟中大多数鸟嘌呤N7位点反应转变为在小沟中聚(A/T)序列3'端的少数腺嘌呤N3位点反应。讨论的氮芥类载体分子有嵌入剂、聚吡咯、聚咪唑、双(苯并咪唑)、聚苯甲酰胺和苯胺喹啉鎓盐。相比之下,多种载体对吡咯里西啶烷基化剂的类似靶向作用对其烷基化模式(在鸟嘌呤的2-氨基处)影响很小。本文还综述了近期关于天然产物小沟结合剂中的吡咯并苯二氮䓬类和环丙烷吲哚酮类的研究工作。